Treatment · June 13, 2026
Experimental Pill for Rare Eye Disease Submitted for FDA Approval
Belite Bio advances toward FDA approval for an oral therapy treating Stargardt disease, a previously untreatable retinal condition...
Treatment · April 30, 2026
Gene Therapy Implant Offers New Hope for Rare Eye Disease Patients
First-in-state surgery successfully treats rare retinal disease using newly approved FDA therapy....